WEREWOLF THERAPEUTICS INCORPORATED (HOWL)

If you are looking for an AI stock ... AI stock. READ NEXT: EPS Alpha: 10 Firms Beating Wall Street Estimates and Beyond Consensus: Earnings Surprises That Shook Wall Street Yesterday. Disclosure: None. Follow Insider Monkey on Google News. NYSE:LYBHeadlineNYSE:NVTNYSE:MGANYSE:ABRNYSE:CRINASDAQ:PWPN…

The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.36, FiscalAI reports. The firm had revenue of $21.00 million for the quarter. Werewolf Therapeutics Trading Down 29.4% Shares of HOWL stock traded down […]

Werewolf Therapeutics (HOWL) on Friday reported a net profit for the second quarter ended June 30, 2026, driven by significant gains from a collaboration revenue.

Werewolf Therapeutics, Inc. reported results for the quarter ended 2Q 2026, recognizing $21M of collaboration revenue from the upfront sale of an asset and posting net income of $3.67M, or diluted EPS of $0.08, compared with a net loss of ($17.98M) and loss per share of ($0.4) in the prior-year ...

Werewolf Therapeutics reported second-quarter 2026 results showing $21.0 million in collaboration revenue and net income of $3.7 million, driven by the sale of the JZP898 program and other transactions. Cash and cash equivalents were $22.0 million as of June 30, 2026, and the company said its ...